1. Home
  2. AAPG vs SIM Comparison

AAPG vs SIM Comparison

Compare AAPG & SIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • SIM
  • Stock Information
  • Founded
  • AAPG 2009
  • SIM 1969
  • Country
  • AAPG China
  • SIM Mexico
  • Employees
  • AAPG N/A
  • SIM N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • SIM Steel/Iron Ore
  • Sector
  • AAPG Health Care
  • SIM Industrials
  • Exchange
  • AAPG Nasdaq
  • SIM Nasdaq
  • Market Cap
  • AAPG 3.6B
  • SIM 4.3B
  • IPO Year
  • AAPG 2025
  • SIM 1993
  • Fundamental
  • Price
  • AAPG $37.20
  • SIM $27.45
  • Analyst Decision
  • AAPG Buy
  • SIM
  • Analyst Count
  • AAPG 1
  • SIM 0
  • Target Price
  • AAPG N/A
  • SIM N/A
  • AVG Volume (30 Days)
  • AAPG 8.5K
  • SIM 635.0
  • Earning Date
  • AAPG 08-11-2025
  • SIM 08-12-2025
  • Dividend Yield
  • AAPG N/A
  • SIM N/A
  • EPS Growth
  • AAPG N/A
  • SIM N/A
  • EPS
  • AAPG N/A
  • SIM 1.84
  • Revenue
  • AAPG $134,352,180.00
  • SIM $1,708,192,766.00
  • Revenue This Year
  • AAPG N/A
  • SIM N/A
  • Revenue Next Year
  • AAPG $404.41
  • SIM N/A
  • P/E Ratio
  • AAPG N/A
  • SIM $15.56
  • Revenue Growth
  • AAPG 341.77
  • SIM N/A
  • 52 Week Low
  • AAPG $16.50
  • SIM $22.15
  • 52 Week High
  • AAPG $43.58
  • SIM $31.00
  • Technical
  • Relative Strength Index (RSI)
  • AAPG N/A
  • SIM 43.41
  • Support Level
  • AAPG N/A
  • SIM $27.65
  • Resistance Level
  • AAPG N/A
  • SIM $28.00
  • Average True Range (ATR)
  • AAPG 0.00
  • SIM 0.04
  • MACD
  • AAPG 0.00
  • SIM -0.03
  • Stochastic Oscillator
  • AAPG 0.00
  • SIM 0.00

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About SIM Grupo Simec S.A.B. de C.V.

Grupo Simec SAB de CV is a diversified producer, processor and distributor of SBQ steel and structural steel products with production and commercial operations. The group's SBQ products are used across a range of engineered end-user applications, including axles, hubs, and crankshafts for automobiles and light trucks, machine tools, and off-highway equipment. Its structural steel products are used in the non-residential construction market and other construction applications. Its segments are Mexico, Brazil, and the United States. The maximum of its sales is from the Mexico segment.

Share on Social Networks: